Beihai Gofar Chuanshan Biological Co., Ltd. (600538) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Beihai Gofar Chuanshan Biological Co., Ltd.

Why is Beihai Gofar Chuanshan Biological Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 1.02%

The company has been able to generate a Return on Capital Employed (avg) of 1.02% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of 4.38% and Operating profit at -250.48% over the last 5 years

Flat results in Jun 25

INTEREST(HY) At CNY 1.09 MM has Grown at 17.99%
PRE-TAX PROFIT(Q) At CNY -8.37 MM has Fallen at -5,203.14%
NET PROFIT(Q) At CNY -8.98 MM has Fallen at -137.92%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 15.64%, its profits have risen by 13.6%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beihai Gofar Chuanshan Biological Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Beihai Gofar Chuanshan Biological Co., Ltd.

15.64%

1.53

34.95%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.38%

EBIT Growth (5y)

-250.48%

EBIT to Interest (avg)

-15.43

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.14

Sales to Capital Employed (avg)

0.42

Tax Ratio

0.21%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.02%

ROE (avg)

1.01%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.30

EV to EBIT

-28.05

EV to EBITDA

-35.44

EV to Capital Employed

3.70

EV to Sales

7.71

PEG Ratio

Dividend Yield

ROCE (Latest)

-13.21%

ROE (Latest)

-10.63%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 0.11 MM

NET PROFIT(HY)

Higher at CNY -5.8 MM

-25What is not working for the Company

INTEREST(HY)

At CNY 1.09 MM has Grown at 17.99%

PRE-TAX PROFIT(Q)

At CNY -8.37 MM has Fallen at -5,203.14%

NET PROFIT(Q)

At CNY -8.98 MM has Fallen at -137.92%

DEBT-EQUITY RATIO (HY)

Highest at -10.68 %

NET SALES(Q)

At CNY 74.31 MM has Fallen at -15.84%

RAW MATERIAL COST(Y)

Grown by 20.58% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.96%

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.17%

Here's what is working for Beihai Gofar Chuanshan Biological Co., Ltd.

Operating Cash Flow

Highest at CNY 0.11 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Here's what is not working for Beihai Gofar Chuanshan Biological Co., Ltd.

Pre-Tax Profit

At CNY -8.37 MM has Fallen at -5,203.14%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -8.98 MM has Fallen at -137.92%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 1.09 MM has Grown at 17.99%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 74.31 MM has Fallen at -15.84%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Debt-Equity Ratio

Highest at -10.68 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Net Sales

Lowest at CNY 74.31 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Inventory Turnover Ratio

Lowest at 2.96%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 1.17%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 20.58% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales